Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Everolimus in Relapsed Lymphoma and Multiple Myeloma
NCT00474929Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2007
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, everolimus in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), multiple myeloma (MM), sponsored by Mayo Clinic. Started Aug 2007; status: completed.
02
Drugs
sorafenibeverolimus
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00474929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00474929.